Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 24531 | 309 | 49.2 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
| 1922 | 2 | RHEUMATOID ARTHRITIS//RADIATION SYNOVECTOMY//RHEUMATOLOGY | 5838 |
| 24531 | 1 | DUBLIN MED//2D GEL CLECTROPHORESIS//ANGIOGENIC ACTIVATOR | 309 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | DUBLIN MED | address | 133391 | 3% | 15% | 9 |
| 2 | 2D GEL CLECTROPHORESIS | authKW | 98819 | 0% | 100% | 1 |
| 3 | ANGIOGENIC ACTIVATOR | authKW | 98819 | 0% | 100% | 1 |
| 4 | ANGIOGENIC GROWTH CAPACITY | authKW | 98819 | 0% | 100% | 1 |
| 5 | ANGIOSTASIS THERAPY | authKW | 98819 | 0% | 100% | 1 |
| 6 | ANGIOSTATIC COMPOUNDS | authKW | 98819 | 0% | 100% | 1 |
| 7 | ANTI FLT 1 PEPTIDE | authKW | 98819 | 0% | 100% | 1 |
| 8 | ANTI IGF 1R MAB | authKW | 98819 | 0% | 100% | 1 |
| 9 | ANTI VEGF RI ANTIBODY | authKW | 98819 | 0% | 100% | 1 |
| 10 | BASEMENT MEMBRANE SYNTHESIS | authKW | 98819 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Rheumatology | 21333 | 48% | 0% | 147 |
| 2 | Immunology | 293 | 16% | 0% | 50 |
| 3 | Medicine, Research & Experimental | 99 | 8% | 0% | 24 |
| 4 | Pathology | 91 | 6% | 0% | 17 |
| 5 | Integrative & Complementary Medicine | 46 | 2% | 0% | 5 |
| 6 | Cell Biology | 39 | 8% | 0% | 24 |
| 7 | Pharmacology & Pharmacy | 30 | 8% | 0% | 26 |
| 8 | CYTOLOGY & HISTOLOGY | 11 | 0% | 0% | 1 |
| 9 | Orthopedics | 11 | 2% | 0% | 7 |
| 10 | Theater | 11 | 0% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | DUBLIN MED | 133391 | 3% | 15% | 9 |
| 2 | EQUIPE ELLISEE LA LIGUE 2003 | 98819 | 0% | 100% | 1 |
| 3 | EULAR | 98819 | 0% | 100% | 1 |
| 4 | FOCIS FEDERAT CLIN IMMUNOL SOC | 98819 | 0% | 100% | 1 |
| 5 | IMMUNOL IMMUNOL DIS RHEUMATOLBK21 PRO | 98819 | 0% | 100% | 1 |
| 6 | INTERNAL MED SEOCHO KU | 98819 | 0% | 100% | 1 |
| 7 | MED DEV BIOL REPAIR | 98819 | 0% | 100% | 1 |
| 8 | MEDSECT ARTHRIT CONNECT TISSUE DIS | 98819 | 0% | 100% | 1 |
| 9 | MITOTHONDRIAL UNIT | 98819 | 0% | 100% | 1 |
| 10 | OYODO KITA KU | 98819 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ARTHRITIS AND RHEUMATISM | 8095 | 9% | 0% | 29 |
| 2 | ARTHRITIS RESEARCH & THERAPY | 5106 | 4% | 0% | 13 |
| 3 | ANNALS OF THE RHEUMATIC DISEASES | 3199 | 6% | 0% | 17 |
| 4 | NATURE REVIEWS RHEUMATOLOGY | 3050 | 1% | 1% | 4 |
| 5 | JOINT BONE SPINE | 2785 | 2% | 0% | 7 |
| 6 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 2471 | 1% | 1% | 3 |
| 7 | JOURNAL OF RHEUMATOLOGY | 1970 | 5% | 0% | 16 |
| 8 | NATURE CLINICAL PRACTICE RHEUMATOLOGY | 1915 | 1% | 1% | 2 |
| 9 | CURRENT OPINION IN RHEUMATOLOGY | 1609 | 2% | 0% | 5 |
| 10 | MODERN RHEUMATOLOGY | 1226 | 1% | 0% | 4 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 2D GEL CLECTROPHORESIS | 98819 | 0% | 100% | 1 | Search 2D+GEL+CLECTROPHORESIS | Search 2D+GEL+CLECTROPHORESIS |
| 2 | ANGIOGENIC ACTIVATOR | 98819 | 0% | 100% | 1 | Search ANGIOGENIC+ACTIVATOR | Search ANGIOGENIC+ACTIVATOR |
| 3 | ANGIOGENIC GROWTH CAPACITY | 98819 | 0% | 100% | 1 | Search ANGIOGENIC+GROWTH+CAPACITY | Search ANGIOGENIC+GROWTH+CAPACITY |
| 4 | ANGIOSTASIS THERAPY | 98819 | 0% | 100% | 1 | Search ANGIOSTASIS+THERAPY | Search ANGIOSTASIS+THERAPY |
| 5 | ANGIOSTATIC COMPOUNDS | 98819 | 0% | 100% | 1 | Search ANGIOSTATIC+COMPOUNDS | Search ANGIOSTATIC+COMPOUNDS |
| 6 | ANTI FLT 1 PEPTIDE | 98819 | 0% | 100% | 1 | Search ANTI+FLT+1+PEPTIDE | Search ANTI+FLT+1+PEPTIDE |
| 7 | ANTI IGF 1R MAB | 98819 | 0% | 100% | 1 | Search ANTI+IGF+1R+MAB | Search ANTI+IGF+1R+MAB |
| 8 | ANTI VEGF RI ANTIBODY | 98819 | 0% | 100% | 1 | Search ANTI+VEGF+RI+ANTIBODY | Search ANTI+VEGF+RI+ANTIBODY |
| 9 | BASEMENT MEMBRANE SYNTHESIS | 98819 | 0% | 100% | 1 | Search BASEMENT+MEMBRANE+SYNTHESIS | Search BASEMENT+MEMBRANE+SYNTHESIS |
| 10 | CHEONG HWA BO UM TANG | 98819 | 0% | 100% | 1 | Search CHEONG+HWA+BO+UM+TANG | Search CHEONG+HWA+BO+UM+TANG |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | HUA, SS , DIAS, TH , (2016) HYPOXIA-INDUCIBLE FACTOR (HIF) AS A TARGET FOR NOVEL THERAPIES IN RHEUMATOID ARTHRITIS.FRONTIERS IN PHARMACOLOGY. VOL. 7. ISSUE . P. - | 38 | 41% | 1 |
| 2 | THAIRU, N , KIRIAKIDIS, S , DAWSON, P , PALEOLOG, E , (2011) ANGIOGENESIS AS A THERAPEUTIC TARGET IN ARTHRITIS IN 2011: LEARNING THE LESSONS OF THE COLORECTAL CANCER EXPERIENCE.ANGIOGENESIS. VOL. 14. ISSUE 3. P. 223-234 | 45 | 33% | 27 |
| 3 | CLAVEL, G , VALVASON, C , YAMAOKA, K , LEMEITER, D , LAROCHE, L , BOISSIER, MC , BESSIS, N , (2006) RELATIONSHIP BETWEEN ANGIOGENESIS AND INFLAMMATION IN EXPERIMENTAL ARTHRITIS.EUROPEAN CYTOKINE NETWORK. VOL. 17. ISSUE 3. P. 202-210 | 27 | 57% | 22 |
| 4 | CLAVEL, G , BESSIS, N , BOISSIER, MC , (2003) RECENT DATA ON THE ROLE FOR ANGIOGENESIS IN RHEUMATOID ARTHRITIS.JOINT BONE SPINE. VOL. 70. ISSUE 5. P. 321-326 | 26 | 62% | 55 |
| 5 | MARUOTTI, N , CANTATORE, FP , CRIVELLATO, E , VACCA, A , RIBATTI, D , (2006) ANGIOGENESIS IN RHEUMATOID ARTHRITIS.HISTOLOGY AND HISTOPATHOLOGY. VOL. 21. ISSUE 4-6. P. 557-566 | 30 | 43% | 86 |
| 6 | FERRARI, M , ONUOHA, SC , PITZALIS, C , (2016) GOING WITH THE FLOW: HARNESSING THE POWER OF THE VASCULATURE FOR TARGETED THERAPY IN RHEUMATOID ARTHRITIS.DRUG DISCOVERY TODAY. VOL. 21. ISSUE 1. P. 172 -179 | 26 | 41% | 1 |
| 7 | OZGONENEL, L , CETIN, E , TUTUN, S , TONBAKLAR, P , ARAL, H , GUVENEN, G , (2010) THE RELATION OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL WITH DISEASE DURATION AND ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS.CLINICAL RHEUMATOLOGY. VOL. 29. ISSUE 5. P. 473 -477 | 17 | 74% | 9 |
| 8 | KONISTI, S , KIRIAKIDIS, S , PALEOLOG, EM , (2012) HYPOXIA-A KEY REGULATOR OF ANGIOGENESIS AND INFLAMMATION IN RHEUMATOID ARTHRITIS.NATURE REVIEWS RHEUMATOLOGY. VOL. 8. ISSUE 3. P. 153-162 | 32 | 27% | 85 |
| 9 | AZIZI, G , BOGHOZIAN, R , MIRSHAFIEY, A , (2014) THE POTENTIAL ROLE OF ANGIOGENIC FACTORS IN RHEUMATOID ARTHRITIS.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. VOL. 17. ISSUE 4. P. 369-383 | 35 | 29% | 9 |
| 10 | MARACLE, CX , TAS, SW , (2014) INHIBITORS OF ANGIOGENESIS: READY FOR PRIME TIME?.BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. VOL. 28. ISSUE 4. P. 637 -649 | 31 | 31% | 5 |
Classes with closest relation at Level 1 |